Incidence and Risk Factors of Treatment-Emergent Eczematous Reactions in Patients with Psoriasis Treated with Biologics: A Systematic Review and Meta-Analysis. (PubMed, BioDrugs) - Oct 17, 2026 - "Eczematous reactions in biologic-treated psoriasis were associated with biologic class, dose, and study population, with the highest incidences for IL-17 inhibitors, high-dose regimens, and studies of East Asian populations."
Journal • Retrospective data • Review • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Oncology • Psoriasis • IL12A • IL17A • IL23A • TYK2
|